RAGWITEK (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the RAGWITEK drug offered from Merck Sharp & Dohme Corp.. This Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] pharmaceutical is classified as a STANDARDIZED ALLERGENIC. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same STANDARDIZED ALLERGENIC drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | Short Ragweed Pollen Allergen Extract |
| SUBSTANCE NAME: | AMBROSIA ARTEMISIIFOLIA POLLEN |
| TYPE: | STANDARDIZED ALLERGENIC |
| PHARMA CLASS: | Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient] |
| ROUTE: | SUBLINGUAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2014-04-17 |
| END MARKETING DATE: | 0000-00-00 |
RAGWITEK STANDARDIZED ALLERGENIC Details:
| Item Description | RAGWITEK from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12([Amb’a’1’U]/1) |
| START MARKETING DATE: | 2014-04-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0006-5420_214a1afa-d839-4f61-99ad-1b65cf7c0b5f |
| PRODUCT NDC: | 0006-5420 |
| APPLICATION NUMBER: | BLA125478 |
Other AMBROSIA ARTEMISIIFOLIA POLLEN Pharmaceutical Manufacturers / Labelers:
